Rising Star Opens New Paths in Glioblastoma Research
Researcher Simin Zheng won an award for her work on repurposing FDA-approved drugs to improve glioblastoma treatment. Her study suggests that certain drugs can cross the blood-brain barrier to enhance the effectiveness of radiotherapy and chemotherapy.
Why it matters
This research offers a potential low-cost, accelerated pathway to improving survival outcomes for patients with one of the most aggressive forms of brain cancer.
Mark Hughes Foundation (MHF) Centre for Brain Cancer Research shared on LinkedIn :
“Congratulations to Simin Zheng who won the Best Poster Award at the School of Biomedical Sciences and Pharmacy ECR/HDR Researcher Showcase. Her poster, Using Drug Repurposing to Target DNA Repair in Brain Cancer , outlined the following research: Glioblastoma (GBM) is the most aggressive type of adult brain cancer and remains difficult to treat despite surgery, radiotherapy, and chemotherapy .
Simin’s research investigates whether FDA-approved drugs that can cross the blood-brain barrier can be repurposed to improve the effectiveness of current GBM treatments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in